Prior Auth Required
07936 - Jersey
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / ServiceJersey
Procedure / Service Description
Updated Accessed - 3 Uplizna (inebilizumab-cdon) prescribing information, Viela Bio, In., Gaithersburg, MD 20878 12/2025 2/2026 4 Vanrafia (atrasentan) prescribing information. Novartis Pharmaceuticals Corporation East Hanover, New 4/2025 2/2026 Jersey 07936 5 Wheeler DC, Toto RD, Stefánsson BV, et al. DAPA-CKD Trial Committees and Investigators. A pre-specified 7/2021 2/2026 analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.